FDA.reportPublic FDA data

RUBBING ALCOHOL 70 PERCENT

Manufacturer
Viny Health and Beauty Products Inc
Effective date
2025-07-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:47:24

Label at a glance#

ProductRUBBING ALCOHOL 70 PERCENT
Active ingredientISOPROPYL ALCOHOL
Label structure12 sections

Indications and uses

FIRST AID TO HELP PREVENT THE RISK IN: MINOR CUTS SCRAPES BURNS

Dosage and administration

CLEAN THE AFFECTED AREA. APPLY A SMALL AMOUNT OF THIS PRODUCT ON THE AREA 1 TO 3 TIMES DAILY MAY BE COVERED WITH A STERILE BANDAGE IF BANDAGED, LET DRY FIRST.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

ISOPROPYL ALCOHOL 70%

Purpose

OTC - PURPOSE SECTION

FIRST AID ANTISEPTIC

Uses

INDICATIONS & USAGE SECTION

FIRST AID TO HELP PREVENT THE RISK IN:

  • MINOR CUTS
  • SCRAPES BURNS

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

FOR RUBBING AND MASSAGING: CAUTION - DO NOT APPLY TO IRRITATED SKIN OR IF EXCESSIVE IRRITATION DEVELOPS. AVOID GETTING INTO THE EYES OR ON MUCOUS MEMBRANES.

WARNINGS

WARNINGS SECTION

For external use only.

  • FLAMMABLE, KEEP AWAY FROM FIRE OR FLAME, HEAT, SPARK, ELECTRICAL.

OTC - ASK DOCTOR SECTION

ASK A DOCTOR BEFORE USE IF YOU HAVE

  • DEEP PUNCTURE WOUNDS SERIOUS BURNS

OTC - WHEN USING SECTION

WHEN USING THIS PRODUCT

  • DO NOT GET INTO EYES
  • DO NOT APPLY OVER LARGE AREAS OF THE BODY.
  • DO NOT USE LONGER THAN 1 WEEK UNLESS DIRECTED BY A DOCTOR.

OTC - STOP USE SECTION

STOP USE AND ASK A DOCTOR IF

  • CONDITION PERSISTS OR GET WORSE.

Directions

DOSAGE & ADMINISTRATION SECTION

  • CLEAN THE AFFECTED AREA.
  • APPLY A SMALL AMOUNT OF THIS PRODUCT ON THE AREA 1 TO 3 TIMES DAILY
  • MAY BE COVERED WITH A STERILE BANDAGE
  • IF BANDAGED, LET DRY FIRST.

OTHER INFORMATION

OTHER SAFETY INFORMATION

  • DOES NOT CONTAIN, NOR IS INTENDED AS A SUBSTITUTE FOR GRAIN OR ETHYL ALCOHOL
  • WILL PRODUCE SERIOUS GASTRIC DISTURBANCES IF TAKEN INTERNALLY.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

WATER

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

lbllbl

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
808520isopropyl alcohol 70 % Topical SolutionPSN1
808520isopropyl alcohol 0.7 ML/ML Topical SolutionSCD1
808520isopropyl alcohol 70 % Topical SolutionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76436-323-12RUBBING ALCOHOL 70 PERCENT355 mL in 1 BOTTLESOLUTION3551

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76436-32376436-323-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
ISOPROPYL ALCOHOLND2M416302ACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RUBBING ALCOHOL 70 PERCENTISOPROPYL ALCOHOLViny Health and Beauty Products Inc4babe369-3a35-34b5-e063-6394a90a68322025-07-01WarningsExact identifier
ndc (package): 76436-323-12
ndc (product): 76436-323
ndc11 (package): 76436032312
spl id: 4babe371-6496-8cc1-e063-6294a90ababf
spl set id: 4babe369-3a35-34b5-e063-6394a90a6832

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.